Keep Your Therapeutic Program On-Track

First and foremost, we understand that many health authorities, governments and biopharmaceutical companies have shifted their focus to the global pandemic and how to prevent, diagnose and treat COVID-19. However, we can’t dismiss the number of novel therapies currently in development or in the approval process for the multitude of other diseases affecting people worldwide. Utilizing the new guidance from FDA and other regulatory agencies, we are here to help keep your current programs moving forward and can address concerns that may arise.

Virtual Clinical Trial Conduct with TelemedicineThe COVID-19 Pandemic is driving the rapid need and adoption of virtual trials where patients are treated at their homes instead of going into a clinical site/office/hospital.  We are running virtual trials right now by designing a customized virtual trial ecosystem to satisfy both the study and patients' needs. 

 We are happy to talk with you and help you keep your program on track. 

 

Information to help you stay the course

Screen Shot 2020-04-24 at 2.47.29 PM FDA ⎪ Conduct of Clinical Trials During COVID-19 Outbreak

Screen Shot 2020-04-24 at 2.47.29 PM

 EMA |  Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) Pandemic. 
Screen Shot 2020-04-24 at 2.47.29 PM MHRA ⎪ Guidance for Clinical Trials During COVID-19 Outbreak
Screen Shot 2020-04-24 at 2.48.34 PM STRATEGIES ⎪ COVID-19 Success Guide 

 

 

Let Us Help You Maintain Trial Integrity 

We understand that the stakes are high no matter where you are in your development program. The stress, anxiety and uncertainty about ongoing,
new, or COVID-19-related clinical programs is overwhelming. We have the agility and scientific-minded experts to help you navigate these uncertain
times.   Schedule an introduction by completing the form below:

 
Request A Proposal